Sign In

Login

Password

Forgot Password ? Sign Up

CD3 (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD3" in Polish language version.

Last modified:

Ref.Un. Ref.Website
Global rank Polish rank
1817nih.gov
5th place
7th place
77doi.org
2nd place
5th place
11archive.org
6th place
24th place

archive.org (Global: 6th place; Polish: 24th place)

doi.org (Global: 2nd place; Polish: 5th place)

  • MS. Kuhns, HB. Badgandi. Piecing together the family portrait of TCR-CD3 complexes.. „Immunol Rev”. 250 (1), s. 120-43, Nov 2012. DOI: 10.1111/imr.12000. PMID: 23046126.
  • CS. Guy, DA. Vignali. Organization of proximal signal initiation at the TCR:CD3 complex.. „Immunol Rev”. 232 (1), s. 7-21, Nov 2009. DOI: 10.1111/j.1600-065X.2009.00843.x. PMID: 19909352.
  • ML. Dustin. Opening the frontier of the T cell surface: schlossman and goldstein.. „J Immunol”. 190 (11), s. 5343-5, Jun 2013. DOI: 10.4049/jimmunol.1300951. PMID: 23687190.
  • BB. Au-Yeung, S. Deindl, LY. Hsu, EH. Palacios i inni. The structure, regulation, and function of ZAP-70.. „Immunol Rev”. 228 (1), s. 41-57, Mar 2009. DOI: 10.1111/j.1600-065X.2008.00753.x. PMID: 19290920.
  • Y. Dean, F. Dépis, M. Kosco-Vilbois. Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases.. „Swiss Med Wkly”. 142, s. w13711, 2012. DOI: 10.4414/smw.2012.13711. PMID: 23254986.
  • A. Kaufman, KC. Herold. Anti-CD3 mAbs for treatment of type 1 diabetes.. „Diabetes Metab Res Rev”. 25 (4), s. 302-6, May 2009. DOI: 10.1002/dmrr.933. PMID: 19319985.
  • C. Penaranda, Q. Tang, JA. Bluestone. Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.. „J Immunol”. 187 (4), s. 2015-22, Aug 2011. DOI: 10.4049/jimmunol.1100713. PMID: 21742976.

nih.gov (Global: 5th place; Polish: 7th place)

ncbi.nlm.nih.gov

  • MS. Kuhns, HB. Badgandi. Piecing together the family portrait of TCR-CD3 complexes.. „Immunol Rev”. 250 (1), s. 120-43, Nov 2012. DOI: 10.1111/imr.12000. PMID: 23046126.
  • CS. Guy, DA. Vignali. Organization of proximal signal initiation at the TCR:CD3 complex.. „Immunol Rev”. 232 (1), s. 7-21, Nov 2009. DOI: 10.1111/j.1600-065X.2009.00843.x. PMID: 19909352.
  • CD247 CD247 molecule [Homo sapiens (human) - Gene - NCBI]. [dostęp 2013-05-25].
  • P. Kung, G. Goldstein, EL. Reinherz, SF. Schlossman. Monoclonal antibodies defining distinctive human T cell surface antigens.. „Science”. 206 (4416), s. 347-9, Oct 1979. PMID: 314668.
  • JP. Van Wauwe, JR. De Mey, JG. Goossens. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.. „J Immunol”. 124 (6), s. 2708-13, Jun 1980. PMID: 6966296.
  • W. de Cock, J. de Cree, H. Verhaegen. Enumeration of human peripheral T lymphocytes with E-rosettes and OKT3. PAN monoclonal antibody: a close correlation.. „Thymus”. 2 (3), s. 133-7, Dec 1980. PMID: 7008282.
  • TW. Chang, PC. Kung, SP. Gingras, G. Goldstein. Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?. „Proc Natl Acad Sci U S A”. 78 (3), s. 1805-8, Mar 1981. PMID: 6165018.
  • ML. Dustin. Opening the frontier of the T cell surface: schlossman and goldstein.. „J Immunol”. 190 (11), s. 5343-5, Jun 2013. DOI: 10.4049/jimmunol.1300951. PMID: 23687190.
  • CD3G CD3g molecule, gamma (CD3-TCR complex) [Homo sapiens (human) - Gene - NCBI]. [dostęp 2013-05-25].
  • CD3D CD3d molecule, delta (CD3-TCR complex) [Homo sapiens (human) - Gene - NCBI]. [dostęp 2013-05-25].
  • LK. Clayton, L. D'Adamio, FD. Howard, M. Sieh i inni. CD3 eta and CD3 zeta are alternatively spliced products of a common genetic locus and are transcriptionally and/or post-transcriptionally regulated during T-cell development.. „Proc Natl Acad Sci U S A”. 88 (12), s. 5202-6, Jun 1991. PMID: 1828894.
  • C. Gerloff, R. Knoth, B. Volk. Cytoplasmic expression of the leu-4 (CD3) antigen in developing Purkinje cells in the rat cerebellum.. „Neuropathol Appl Neurobiol”. 19 (4), s. 313-23, Aug 1993. PMID: 8232751.
  • BB. Au-Yeung, S. Deindl, LY. Hsu, EH. Palacios i inni. The structure, regulation, and function of ZAP-70.. „Immunol Rev”. 228 (1), s. 41-57, Mar 2009. DOI: 10.1111/j.1600-065X.2008.00753.x. PMID: 19290920.
  • Y. Dean, F. Dépis, M. Kosco-Vilbois. Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases.. „Swiss Med Wkly”. 142, s. w13711, 2012. DOI: 10.4414/smw.2012.13711. PMID: 23254986.
  • A. Kaufman, KC. Herold. Anti-CD3 mAbs for treatment of type 1 diabetes.. „Diabetes Metab Res Rev”. 25 (4), s. 302-6, May 2009. DOI: 10.1002/dmrr.933. PMID: 19319985.
  • C. Penaranda, Q. Tang, JA. Bluestone. Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.. „J Immunol”. 187 (4), s. 2015-22, Aug 2011. DOI: 10.4049/jimmunol.1100713. PMID: 21742976.
  • JJ. van Dongen, GW. Krissansen, IL. Wolvers-Tettero, WM. Comans-Bitter i inni. Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies.. „Blood”. 71 (3), s. 603-12, Mar 1988. PMID: 3278747.